GlassScriptPhysician profile
Gregory L Bearden
NPI 1811945447
$3,031.67
in general payments reported to CMS, 2019-2025
34 companies · $271 in 2025
The $271 reported for 2025 was less than what a typical Surgery provider received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $842 · 2020: $66.08 · 2021: $490 · 2022: $570 · 2023: $582 · 2024: $212 · 2025: $271.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,064.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,064.15 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Organogenesis INC. | $517.11 | 2019-2023 | Puraply |
| Davol INC. | $476.96 | 2022-2025 | Phasix Mesh |
| Intuitive Surgical, INC. | $389.87 | 2019-2023 | Da Vinci Surgical System |
| Ethicon US, LLC | $204.63 | 2023-2025 | Vistaseal, Ethicon |
| Sanara Medtech INC. | $182.63 | 2021 | |
| Stryker Corporation | $174.55 | 2023 | Spy-Phi System |
| La Jolla Pharmaceutical Company | $121.40 | 2022 | |
| Acera Surgical, INC. | $102.70 | 2019 | |
| Abbvie INC. | $93.90 | 2021-2022 | |
| Acell, INC. | $86.47 | 2019 | |
| Smith+Nephew, INC. | $70.16 | 2020-2022 | |
| Aroa Biosurgery Incorporated | $64.32 | 2023 | |
| Novartis Pharmaceuticals Corporation | $58.14 | 2024-2025 | |
| Merck Sharp & Dohme LLC | $45.36 | 2024-2025 | Lynparza, Keytruda |
| Apollo Endosurgery US INC | $39.65 | 2021 |
Show all 34 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Solventum Corporation | $37.94 | 2025 | Activ.A.C. |
| Janssen Pharmaceuticals, INC | $31.72 | 2019 | |
| Nestle Healthcare Nutrition INC. | $31.35 | 2022 | |
| Allergan, INC. | $29.61 | 2019 | |
| Convatec INC. | $28.25 | 2019 | |
| Daiichi Sankyo INC. | $24.92 | 2024 | Enhertu |
| Conmed Corporation | $24.80 | 2022 | |
| Polynovo North America LLC | $22.24 | 2022 | |
| Mallinckrodt Hospital Products INC. | $19.19 | 2021 | |
| Paratek Pharmaceuticals, INC. | $18.53 | 2019 | |
| Cumberland Pharmaceuticals, INC. | $18.14 | 2019 | |
| Osiris Therapeutics INC. | $17.98 | 2019 | |
| Musculoskeletal Transplant Foundation INC. | $16.82 | 2022 | |
| Hartmann USA, INC. | $16.37 | 2021 | |
| Covidien LP | $15.86 | 2019 | |
| Globus Medical, INC. | $15.54 | 2022 | |
| Melinta Therapeutics, LLC | $14.12 | 2019 | |
| Integra Lifesciences Corporation | $10.87 | 2019 | |
| Medela LLC | $9.57 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Gregory Bearden listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.